NICE backs ibrutinib regimen for untreated mantle cell lymphoma
Guidance offers first alternative to transplant‑based first‑line care
Read More
Author: John Pinching
Eric Muller
Lucid Group appointed Eric Muller as Chief Executive Officer
Read More
Andrew Fenny
Andrew Fenny has been appointed President of Pace Life Sciences
Read More
Livdelzi accepted in Scotland for treatment of PBC
SMC decision expands options for people with chronic itch
Read More
Khatera Alawi
DFE Pharma has made Khatera Alawi Global Director HR
Read More
